Belmont HIPEC (Hyperthermic Intraperitoneal Chemotherapy) systems are advanced perfusion solutions designed to deliver precisely controlled, heated chemotherapy directly into the peritoneal cavity following cytoreductive surgery.
Engineered for accuracy, safety, and thermal stability.
Help clinicians maintain consistent target temperatures and flow rates.
Support effective drug distribution while minimizing systemic toxicity.
Widely used in complex oncologic procedures for the treatment of peritoneal surface malignancies.
Key Features
Precise Temperature Control: Maintains stable hyperthermic conditions to enhance chemotherapy efficacy while protecting surrounding tissues.
Accurate Flow & Volume Management: Controlled perfusion ensures uniform distribution of chemotherapeutic agents throughout the peritoneal cavity.
Integrated Safety Mechanisms: Continuous monitoring of temperature, pressure, and flow with alarms to support patient safety.
User-Friendly Interface: Intuitive controls and clear displays simplify setup, monitoring, and intraoperative adjustments.
Reliable Heating Technology: Efficient heat exchangers provide rapid warm-up and consistent thermal performance.
Clinical Versatility: Suitable for a range of HIPEC protocols and chemotherapeutic regimens across oncology centers.
Durable & OR-Ready Design: Built for demanding surgical environments with dependable, repeatable performance.
Compatibility with Certified Consumables: Designed to work seamlessly with approved tubing sets and accessories to ensure system integrity and infection control.
